Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 69,749 | 37,655 | 23,634 | 70,686 | 70,345 |
| Marketable Securities | 10,886 | 12,662 | 26,344 | 47,175 | 63,259 |
| Receivables | 32,725 | 26,524 | 24,469 | 24,190 | 24,715 |
| Inventories | 9,651 | 11,308 | 9,976 | 17,961 | 20,697 |
| Other current assets | 4,878 | 4,784 | 3,143 | 9,008 | 8,072 |
| TOTAL | $133,111 | $100,760 | $96,373 | $176,957 | $196,048 |
| Non-Current Assets | |||||
| PPE Net | 53,237 | 54,861 | 51,971 | 43,634 | 42,530 |
| Investments And Advances | 12,008 | 12,008 | 17,176 | 55,605 | 50,739 |
| Intangibles | 202,552 | 204,144 | 217,171 | 251,639 | 253,917 |
| Other Non-Current Assets | 55,784 | 88,290 | 90,149 | 87,779 | 88,898 |
| TOTAL | $323,581 | $359,303 | $376,467 | $438,657 | $436,084 |
| Total Assets | $456,692 | $460,063 | $472,840 | $615,614 | $632,132 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 120,362 | 49,635 | 16,286 | 52,907 | 23,714 |
| Accounts payable and accrued liabilities | 19,069 | 14,981 | 55,315 | 46,061 | 32,474 |
| Accrued Expenses | 98,888 | 74,169 | 241,092 | 88,961 | 74,210 |
| Other current liabilities | 397 | 397 | 397 | 397 | 397 |
| TOTAL | $264,949 | $165,632 | $327,922 | $201,980 | $145,321 |
| Non-Current Liabilities | |||||
| Long Term Debt | 21,741 | 21,400 | 19,130 | 17,800 | 83,069 |
| Deferred Revenues | 256 | 252 | 652 | 281 | 1,018 |
| Other Non-Current Liabilities | 380,148 | 414,240 | 143,190 | 147,709 | 148,894 |
| TOTAL | $389,699 | $421,851 | $166,587 | $283,428 | $351,048 |
| Total Liabilities | $654,648 | $587,483 | $494,509 | $485,408 | $496,369 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 551,281 | 551,281 | 551,281 | 471,880 | 449,952 |
| Common Shares | 55 | 55 | 52 | 47 | 18 |
| Retained earnings | -2,194,275 | -2,099,063 | -1,959,447 | -1,735,755 | -1,646,178 |
| Other shareholders' equity | 8,933 | -560 | -2,027 | -1,880 | 4,113 |
| TOTAL | $-197,956 | $-127,420 | $-21,669 | $130,206 | $135,763 |
| Total Liabilities And Equity | $456,692 | $460,063 | $472,840 | $615,614 | $632,132 |